Protective effects of cannabidiol on cuprizone-induced demyelination in C57BL/6 mice

Authors

  • Maryam Sajjadian Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Iraj Ragerdi Kashani Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Parichehr Pasbakhsh Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Mahmoud Hassani Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ameneh Omidi Department of Anatomical Sciences, Medical Sciences Faculty, Tarbiat Modares University, Tehran, Iran.
  • Nasrin Takzare Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Tim Clarner Faculty of Medicine, Institute of Neuroanatomy, RWth Aachen University, Aachen, Germany.
  • Cordian Beyer Faculty of Medicine, Institute of Neuroanatomy, RWth Aachen University, Aachen, Germany.
  • Adib Zendedel Faculty of Medicine, Institute of Neuroanatomy, RWth Aachen University, Aachen, Germany.

Abstract

Objective Experimental and clinical studies suggest that oxidative stress plays an important role in the pathogenesis of multiple sclerosis. In this study, we have investigated the effects of the non-psychoactive cannabinoid cannabidiol (CBD), which exerts antioxidant effects and has recently been approved for the treatment of inflammation, pain, and spasticity associated with MS patients and in a MS mouse model, i.e. cuprizone-induced demyelination.
Methods Adult male BL/6 mice were fed with 0.2% cuprizone for 5 weeks, which caused severe demyelination of the corpus callosum (CC). Animals were simultaneously treated with 5 mg·kg−1 CBD by daily intra-peritoneal injections. Using immunohistochemistry and transmission electron microscope, we evaluated the effects of CBD on demyelination, malondialdehyde levels and the activity of reduced glutathione, catalase and superoxide dismutase was evaluated by Biochemical analysis.
Results CBD ameliorate the cuprizone-induced demyelination and microglia accumulation. Biochemical analysis showed that oxidative stress induced by cuprizone was reduced by CBD.
Conclusion Our data implicate that CBD attenuates destructive cuprizone effects in the CC by decreasing oxidative stress and as well microglia repletion.
Keywords cannabidiol, demyelination, oxidative stress, microglia, cuprizone

Downloads

Published

2017-09-26

How to Cite

Sajjadian, M., Ragerdi Kashani, I., Pasbakhsh, P., Hassani, M., Omidi, A., Takzare, N., Clarner, T., Beyer, C., & Zendedel, A. (2017). Protective effects of cannabidiol on cuprizone-induced demyelination in C57BL/6 mice. Journal of Contemporary Medical Sciences, 3(11), 278–283. Retrieved from https://jocms.org/index.php/jcms/article/view/225

Most read articles by the same author(s)